work

Galleries and Reading Room

Café

Shop

Library

Our building is closed due to a fault. If you've got a ticket to an event this evening, these are still going ahead. We expect to be open again at 10am Friday.

We’re undertaking some research with website visitors to learn more about how people find access-related information provided by museums. This survey shouldn't take longer than 10 minutes to complete. Thank you for your time!

Help us organize our website content.

RESEARCH WORK RELATING TO BRITISH ANTI -LEWISITE (BAL) AND CHEMICAL WEAPONS

Research and Development

Detailed list of articles and reports

Report to Chemical Board Physiological and Medical Sub-Committees. 'Comparison of the Value in Practice of D.T.H. or other Remedies in Lewisite (or M.A.) Poisoning'

'A Procedure for the Treatment of Gas Casualties', L A Stocken and RHST, BMJ

'Toxicity of T1024 and other Compounds of Cholinesterase'

Relative Results of Tests upon Dithiol Compounds (Preliminary Compilation)' with 'List of Dithiol Compounds' Research report [Work probably originated in the USA], [post may 1943]

'Tentative Specification for BAL Ointment'. With letter to Professor Peters

'Specification of BAL Stabilised and of BAL Ampoules' (draft)

'The Esterases of Skin', RHST and V P Whittaker, The Biochemical Journal, vol 38, no 4, pp 295-299

'British Anti-Lewisite (BAL)', Nature, no 156 (ts rather than published version)

'BAL (British Anti-Lewisite)'Compiled by Dr L L Waters and Dr Chester Stock, Science, vol 102, no 2659, pp 601-606

'British Anti-Lewisite' L A Stocken and RHST The Biochemical Journal, vol 40, no 4

'Clinical Uses of 2, 3-Dimercaptopropanol (BAL). vi. The Treatment of Complications of Arseno-Therapy with BAL (British Anti-Lewisite)', A B Carleton, R A Peters, L A Stocken, RHST and D I Williams, The Journal of Clinical Investigation, vol XXV, no 4, pp 497-527

'The Systemic Treatment of Arsenic Poisoning with BAL (2, 3 -Dimercaptopropanol)', Harry Eagle, Senior Surgeon, US Public Health Service, Journal of Venereal Disease Information, vol 27, pp 114-121

'Clinical Uses of 2, 3-Dimercaptopropanol (BAL) One: The Systemic Treatment of Experimental Arsenic Poisoning', Harry Eagle, Harold Magnuson and Ralph Fleischman, Journal of Clinical Investigation, vol XXV, no 4 pp 451-466

'Clinical uses of 2, 3-Dimercaptopropanol (BAL) Two: The Effect of BAL on the Excretion of Arsenic', J Weixler, H Eagle, H J Tatum, H J Magnuson and E B Watson, Journal of Clinical Investigation

'Clinical uses of 2, 3-Dimercaptopropanol (BAL) Eight: the Effect of BAL on the Excretion of Arsenic in Arsenical Intoxication', A Leutscher Jr, Harry Eagle and Warfield T Longcope, Journal of Clinical Investigation

'The Systemic Treatment of 227 cases of Arsenic Poisoning with 2, 3 Dimercaptopropanol (BAL)', Harry Eagle and Harold J Magnuson, American Journal of Syphilis, Gonorrhoea and Venereal Diseases, vol 30, no 5, pp 420-411

'An Analysis of the Inhibition of Pyruvate Oxidation by Arsenicals in relation to the Enzyme Theory of Vesication' R A Peters, H M Sinclair and RHST, The Biochemical Journal, vol 40, no 4, pp 516-524

'Symposium on the Pharmacology of Dithiols' Supplement to the Journal of Pharmacology and Experimental Therapeutics, vol 87, no 4

'The Treatment of Two Reactions due to Gold. Response of Thrombopenic Purpura and Granulocytopenia to BAL Therapy', L Maxwell Lockie, B M Norcross and C W George, Journal of the American Medical Association, vol 133, pp 754-755

'The Treatment of Acute Gold and Arsenic Poisoning Use of BAL (2, 3-Dimercaptopropanol, British Anti-Lewisite)', Abraham Cohen, Joel Goldman and Alfred W Dubbs, Journal of the American Medical Association, vol 133, pp 749-752

'British Anti-Lewisite. Its Use and Therapeutic Value in Arsenical Intoxications', R A Peters et al. Report from BAL Conference, MRC, The Lancet

'Further Investigations on the Metabolism of 2:3 Dimercaptopropanol', G H Spray, L A Stocken and RHST, The Biochemical Journal, vol 41, no 3, pp 362-366

'The Action of Chemical Vesicants on Cholinesterase' HST, The Journal of Physiology, vol 105, no 4, p 370

'The Development of British Anti-Lewisite', RHST.  Report from the 262nd meeting of the Biochemical Society (Uncorrected proof)

'Treatment of Arsenical Dermatitis with Dimercaptopropanol (BAL)', A B Carleton, R A Peters and RHST, Quarterly Journal of Medicine, no 65, pp 49-79

'The Selective Inhibition of Cholinesterases', D H Adams and RHST, The Biochemical Journal, vol m42, no 2, pp 170-175

'Therapeutic Applications of British Anti-Lewisite' RHST, British Medical Bulletin, vol 5, nos 4-5, pps 319-324

British Anti-Lewisite. A report on its use and Therapeutic Value in Arsenical Intoxications' From the BAL Conference, Medical Research Council (final draft) [post 1946]

'British Anti-Lewisite. A report on its use and Therapeutic Value in Arsenical Intoxications' From the BAL Conference, Medical Research Council (final draft) with covering letter

'British Anti Lewisite Its Use and Therapeutic Value in Arsenical Intoxications' A Report for The BAL Conference, MRC, The Lancet, p 497

'BAL Therapy of Severe Peripheral Neuropathies', A R Furmanski, Arch. Neurol. Psych, vol 60, no 3, pp 270-278

'Treatment of Accidental Arsenical Poisoning with Dimercaprol', D A W Rittey, The Lancet

'BAL and BAL (Intrav)' Position as at 1st September 1952

Specification for BAL Ampoules.  MRC Report (47/393), annotated

Wellcome uses cookies.

Specification for BAL Ampoules. MRC Report (47/393), annotated

Collection contents

About this work

Publication/Creation

Physical description

Permanent link